Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性自我给药的单核基因表达
基本信息
- 批准号:10592330
- 负责人:
- 金额:$ 131.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-15 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAlzheimer&aposs DiseaseAnimal ModelAstrocytesAutomobile DrivingBehaviorBehavioral ParadigmBindingBrain regionCell NucleusCellsCentral Nervous SystemChronicClinicalComputing MethodologiesDSM-IVDataData Coordinating CenterDevelopmentDiseaseDisease ProgressionDrug AddictionDrug usageFreezingGene ExpressionGenesGenomicsGoalsHIVHIV InfectionsHIV-1HeadHumanImpairmentIntakeIntravenousLymphocyteMacrophageMalignant NeoplasmsMethamphetamineMethamphetamine use disorderMethodsMicrogliaModelingMolecularNerve DegenerationNeuronsNeuropathogenesisNeuropsychologyNeurosciencesPathogenicityPathway AnalysisPatientsPatternPersonsPharmaceutical PreparationsProteinsRat TransgeneRattusRecording of previous eventsRecreationRegulationRegulator GenesResearch PersonnelResolutionResourcesRodent ModelSamplingSelf AdministrationSubstance Use DisorderSynapsesSystems BiologyTestingTherapeuticTissuesTranscriptTransgenesTransgenic OrganismsValidationViruscell typecomorbiditydrug mechanismexperiencegene networkgene regulatory networkgenetic signaturegenome-widehigh throughput analysisimprovedmethamphetamine abusemethamphetamine effectmethamphetamine usenerve injuryneuralneuroAIDSneuroinflammationnew therapeutic targetnovelnovel therapeuticspublic health relevancereconstructionsingle cell analysissingle nucleus RNA-sequencingstimulant abusetargeted treatmenttherapeutic targettranscriptomicsvalidation studies
项目摘要
Summary
The abuse of stimulants such as methamphetamine (METH) exacerbates the deleterious effects of HIV
infection. Here, we will carry out single nucleus RNA-Seq with the goal of identifying cell types and cell states
that are pivotal in the effects of HIV and chronic methamphetamine (METH) self-administration on key brain
regions relevant to the effects of persistent HIV infection and METH use disorder in HIV transgenic (Tg) rats,
which harbor a non-replicating HIV-1 transgene and express chronic low-levels of multiple HIV-1 proteins. The
occasional but limited use of a drug is clinically distinct from escalated drug use, which is characterized by the
emergence of chronic compulsive drug-seeking and taking. Thus, we will use an established, state-of-the-art
paradigm of voluntary intravenous drug self-administration under long access (LgA) conditions that leads to
escalated (compulsive) METH intake in comparison to self-administration under short access (ShA) conditions,
which leads to a moderate and stable pattern of METH intake. The paradigm of escalated drug intake under
LgA conditions is highly relevant to the human substance use disorder (SUD) as it models all 7 of the criteria
for drug addiction in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV and 7 of the 11 criteria
in the DSM-V. We showed that HIV Tg rats self-administering METH in this paradigm display increased
compulsivity, neuroinflammation, and neural injury. The project will address the following vexing question about
persistent HIV infection in the CNS: what are the cell types and cell states that drive neuroinflammation,
neurodegeneration, and compulsive METH abuse in the setting of HIV that can reveal the pathogenic
mechanisms behind neuroHIV disease progression, virus expression and persistence? The overarching
hypothesis behind the present project is that the exploration of the gene regulatory network at the single cell
level will elucidate key mechanisms that underlie the effects of HIV and METH abuse and their detrimental
interactions on neuroHIV disease progression, virus expression, and virus persistence and will indicate novel
therapeutic targets for neuroinflammation, neurodegeneration, and compulsivity to take METH. To test this
hypothesis, we will use a validated systems biology strategy for the reconstruction and interrogation of
genome-wide gene regulatory networks to identify the gene network dysregulations associated with the effects
of HIV, compulsive METH use, and their interactions at single cell resolution gene profiling by single nucleus
RNA-Seq. Overall, this collaborative interdisciplinary proposal integrating single cell level transcriptomics,
state-of-the-art behavior methods in HIV Tg and wild-type rats, and computational strategies is expected to
identify novel mechanistic hypotheses that may lead to transformative new therapeutic concepts for substance
use disorder (SUD) in the HIV setting, and will establish key resources for the neuroHIV field to be made
publicly available through the SCORCH data coordination center.
概括
滥用甲基苯丙胺 (METH) 等兴奋剂会加剧艾滋病毒的有害影响
感染。在这里,我们将进行单核 RNA-Seq,目的是识别细胞类型和细胞状态
HIV 和慢性甲基苯丙胺 (METH) 自我给药对关键大脑的影响至关重要
与艾滋病毒转基因(Tg)大鼠中持续艾滋病毒感染和冰毒使用障碍的影响相关的区域,
它含有非复制型 HIV-1 转基因,并长期表达低水平的多种 HIV-1 蛋白。这
偶尔但有限地使用药物在临床上与逐步增加的药物使用不同,后者的特点是
出现慢性强迫性寻药和吸毒现象。因此,我们将使用一个成熟的、最先进的
在长通路(LgA)条件下自愿静脉注射药物自我给药的范例,导致
与短时间(ShA)条件下的自我管理相比,METH 摄入量增加(强迫性),
这导致冰毒摄入量适度且稳定。药物摄入量递增的范式
LgA 状况与人类物质使用障碍 (SUD) 高度相关,因为它模拟了所有 7 个标准
《精神疾病诊断与统计手册》(DSM)-IV 中针对药物成瘾的规定以及 11 项标准中的 7 项
在 DSM-V 中。我们发现,HIV Tg 大鼠在这种范式中自我施用 METH 后,显示增加
强迫症、神经炎症和神经损伤。该项目将解决以下令人烦恼的问题
中枢神经系统中持续的艾滋病毒感染:驱动神经炎症的细胞类型和细胞状态是什么?
神经退行性变和艾滋病毒背景下强迫性滥用冰毒可以揭示致病原因
神经艾滋病毒疾病进展、病毒表达和持久性背后的机制?首要的
本项目背后的假设是探索单细胞的基因调控网络
水平将阐明艾滋病毒和冰毒滥用及其有害影响的关键机制
神经艾滋病毒疾病进展、病毒表达和病毒持久性之间的相互作用,并将表明新的
神经炎症、神经退行性变和强迫性服用冰毒的治疗目标。为了测试这个
假设,我们将使用经过验证的系统生物学策略来重建和询问
全基因组基因调控网络,以确定与效应相关的基因网络失调
HIV、强迫性冰毒使用以及它们在单细胞分辨率基因分析中的相互作用
RNA测序。总体而言,这一跨学科协作提案整合了单细胞水平转录组学,
HIV Tg 和野生型大鼠中最先进的行为方法和计算策略预计将
确定新的机制假设,这些假设可能会导致物质的变革性新治疗概念
艾滋病毒使用障碍(SUD),并将为神经艾滋病毒领域建立关键资源
通过 SCORCH 数据协调中心公开可用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PIETRO P SANNA其他文献
PIETRO P SANNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PIETRO P SANNA', 18)}}的其他基金
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性阿片类药物自我给药的单核基因表达
- 批准号:
10682961 - 财政年份:2023
- 资助金额:
$ 131.89万 - 项目类别:
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
- 批准号:
10540014 - 财政年份:2022
- 资助金额:
$ 131.89万 - 项目类别:
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
- 批准号:
10686229 - 财政年份:2022
- 资助金额:
$ 131.89万 - 项目类别:
Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性自我给药的单核基因表达
- 批准号:
10454706 - 财政年份:2022
- 资助金额:
$ 131.89万 - 项目类别:
An Innovative Approach to Identify Correctors of Metabolic Complications in HIV
一种识别 HIV 代谢并发症校正因子的创新方法
- 批准号:
10395011 - 财政年份:2021
- 资助金额:
$ 131.89万 - 项目类别:
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders
HIV/艾滋病和药物滥用疾病中 RNA 修饰的系统生物学
- 批准号:
10318620 - 财政年份:2018
- 资助金额:
$ 131.89万 - 项目类别:
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
鉴定治疗 HIV 神经并发症和药物滥用合并症的小分子
- 批准号:
10343707 - 财政年份:2018
- 资助金额:
$ 131.89万 - 项目类别:
Epigenetic regulation of alcohol tolerance and dependence by methyl CpG binding protein 2
甲基 CpG 结合蛋白 2 对酒精耐受性和依赖性的表观遗传调控
- 批准号:
9133075 - 财政年份:2017
- 资助金额:
$ 131.89万 - 项目类别:
Neural substrates of opiate-HIV interactions.
阿片类药物与艾滋病毒相互作用的神经基质。
- 批准号:
9344568 - 财政年份:2016
- 资助金额:
$ 131.89万 - 项目类别:
Cocaine abuse and plasticity in the lateral hypothalamus
可卡因滥用和外侧下丘脑的可塑性
- 批准号:
8989877 - 财政年份:2015
- 资助金额:
$ 131.89万 - 项目类别:
相似国自然基金
基于空间代谢流技术探究人参-远志药对通过纠偏单胺类神经递质代谢紊乱治疗阿尔茨海默病的整合作用模式
- 批准号:82304894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
酵母β-葡聚糖通过调控C/EBPβ/AEP信号通路对阿尔茨海默病防控作用及其机制研究
- 批准号:82304140
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
萱草花通过调节小胶质细胞焦亡与Tau病理的crosstalk抗阿尔茨海默病的药效物质基础及作用机制研究
- 批准号:82304710
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
牙周炎在肠-脑轴中通过TMAO对阿尔茨海默病的作用及机制研究
- 批准号:82301103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道微生物代谢产物马尿酸通过激活C/EBPβ/AEP通路促进阿尔茨海默病发生的机制研究
- 批准号:82301606
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dissemination of the Human Neocortical Neurosolver (HNN) software for circuit level interpretation of human MEG/EEG
传播用于人类 MEG/EEG 电路级解释的人类新皮质神经解算器 (HNN) 软件
- 批准号:
10726032 - 财政年份:2023
- 资助金额:
$ 131.89万 - 项目类别:
Astrocyte-specific in vivo molecular signatures of APOE genetic risk in Alzheimer's disease
阿尔茨海默病 APOE 遗传风险的星形胶质细胞特异性体内分子特征
- 批准号:
10679977 - 财政年份:2023
- 资助金额:
$ 131.89万 - 项目类别:
Deprescribing antipsychotics in patients with Alzheimers disease and related dementias and behavioral disturbance in skilled nursing facilities
在熟练护理机构中取消阿尔茨海默病及相关痴呆症和行为障碍患者的抗精神病药物处方
- 批准号:
10634934 - 财政年份:2023
- 资助金额:
$ 131.89万 - 项目类别: